Pacira Pharmaceuticals, Inc.
Clinical trials sponsored by Pacira Pharmaceuticals, Inc., explained in plain language.
A pharmaceutical company focused on non-opioid pain management therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a freezing device loosen stiff muscles? new trial begins Results expected Oct 2026 (estimated)
- One-Shot gene therapy could ease knee arthritis pain for years Results expected Nov 2026 (estimated)
- New shot aims to ease shoulder arthritis pain Results expected Dec 2026 (estimated) 🚀 Make-or-break
- New pain relief for tiny hearts: study tests EXPAREL in kids under 6 Results expected Jan 2027 (estimated)
-
One shot, new knee? gene therapy trial aims to quiet arthritis pain
Symptom relief OngoingResearchers are testing FX201, an experimental gene therapy, in adults aged 30 to 80 with painful knee osteoarthritis. Participants receive a single injection of FX201 into the affected knee. The study first checks safety at increasing doses, then gives more people the same dose …
Phase 1 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a freezing device loosen stiff muscles? new trial begins
Symptom relief OngoingThis study tests a device called iovera® that uses cold to calm overactive nerves causing muscle tightness in the arm and shoulder. About 132 adults with spasticity from a brain or spinal condition will get either the real device or a sham (fake) treatment. Researchers will measu…
Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New shot aims to ease shoulder arthritis pain
Symptom relief OngoingThis study tests whether an injection called ZILRETTA can reduce pain in people with shoulder osteoarthritis. About 150 adults aged 50 to 80 will receive either ZILRETTA, a standard steroid, or a placebo. The main goal is to see if ZILRETTA provides better pain relief over 12 wee…
Phase 3 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC